Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
Jan 30, 2018
| Rachel Schwartz
AAM Member Fresenius Kabi Testifies Before Congress on Drug Compounding
Blog
Jan 25, 2018
| Erik Komendant
Anti-Competitive Evergreening Delays Patient Access to More Affordable Generics and Biosimilars
Blog
Jan 9, 2018
| Erica Klinger
Access! 2017 Recap: Ramping Up for AAM’s 2018 Annual Meeting
Blog
Dec 15, 2017
| Erica Klinger
House Subcommittee Examines the Drug Supply Chain
Blog
Dec 14, 2017
| Rachel Schwartz
The Right People in the Room to Prevent Opioid Abuse on Campus
Blog
Nov 28, 2017
| Erica Klinger
Seeking Asylum for Its Patents on Tribal Lands: The Latest Brand-Name Drug Company Strategy to Preserve Monopoly Pricing
Blog
Nov 21, 2017
| Erica Klinger
#EndtheShenanigans, Says Gottlieb
Blog
Nov 20, 2017
| Erica Klinger
Recap: AAM’s FallTech Conference 2017
Blog
Nov 16, 2017
| Erica Klinger
How the Medicaid Generics Penalty Jeopardizes Patient Access
Blog
Nov 9, 2017
| Erica Klinger
The Medicaid Generics Penalty: Barrier to Generic Competition (Part 3)
Blog
Nov 2, 2017
| Erica Klinger
The Medicaid Generics Penalty: Understanding Market Dynamics (Part 2)
Blog
Nov 2, 2017
| Rachel Schwartz
Five Reasons to Attend the 2017 FallTech Conference
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action